Kinney Horn - 10 Mar 2022 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role: CHIEF BUSINESS OFFICER
Signature: /s/ John B. Moriarty, Jr., Attorney-in-Fact
Issuer symbol: OLMA
Transactions as of: 10 Mar 2022
Net transactions value: -$14,110
Form type: 4
Filing time: 14 Mar 2022, 16:45:56 UTC
Previous filing: 14 Feb 2022
Next filing: 02 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OLMA	Common Stock	Options Exercise	$10,842	+5,253	+214%	$2.06^*	7,711	10 Mar 2022	Direct
transaction	OLMA	Common Stock	Sale	$24,952	-5,253	-68%	$4.75	2,458	10 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OLMA	Stock Option (Right to Buy)	Options Exercise	$0	-5,253	-3.6%	$0.000000	141,785	10 Mar 2022	Common Stock	5,253	$2.06	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
F2	The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date.